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Non-medical prescribing was introduced into the United Kingdom to improve patient care,
but early research indicated a third of Allied Health Professionals may not use their prescrib-
ing qualification. A previous literature review, highlighting factors influencing prescribing,
identified only papers with nursing and pharmacy participants. This investigation explored
consensus on factors affecting physiotherapist and pharmacist non-medical prescribers. A
three round Delphi study was conducted with pharmacist and physiotherapist prescribers.
Round One comprised information gathering on facilitators and barriers to prescribing par-
ticipants had experienced, and underwent content analysis. This was followed by two
sequential consensus seeking rounds with participants asked to rate the importance of
statements to themselves. Consensus criteria were determined a priori, including median,
interquartile range, percentage agreement and Kendall’s Coefficient of Concordance (W).
Statements reaching consensus were ranked for importance in Round Three and analysed
to produce top ten ranks for all participants and for each professional group. Participants,
recruited October 2018, comprised 24 pharmacists and 18 physiotherapists. In Round One,
content analysis of 172 statements regarding prescribing influences revealed 24 themes.
127 statements were included in Round Two for importance rating (barriers = 68, facilitators
= 59). After Round Two, 29 statements reached consensus (barriers = 1, facilitators = 28),
with no further statements reaching consensus following Round Three. The highest ranked
statement in Round Three overall was: “Being able to prescribe to patients is more effective
and really useful working [in my area]”. Medical support and improved patient care factors
appeared the most important. Differences were noted between physiotherapist and pharma-
cist prescribers regarding the top ten ranked statements, for example team working which
pharmacists ranked higher than physiotherapists. Differences may be explained by the vari-
ety of practice areas and relative newness of physiotherapy prescribing. Barriers appear to
be post or person specific, whereas facilitators appear universal.
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Introduction
Non-medical prescribing (NMP) (prescribing by professions other than the medical profes-
sion) was introduced in the United Kingdom (UK) to improve patient care and access to medi-
cines, following the second Crown report [1]. The UK recognises two main approaches to
NMP; supplementary and independent. Supplementary prescribers can only prescribe from a
clinical management plan agreed by the doctor treating the patient, supplementary prescriber
and patient [2]. Independent prescribers are responsible for patient care, including assessment
and prescribing [3] and may prescribe any drugs detailed by profession specific legislation and
regulations [4]. Initially only nurses and pharmacists could become non-medical prescribers,
gaining independent prescribing rights in 2006. Subsequently there has been a gradual expan-
sion to other professions [5, 6].
Since NMP introduction, with the UK National Health Service (NHS) experiencing
increased patient demand, workforce shortage pressures and funding shortfalls, the policy
emphasis has changed to streamlining care [5, 7, 8]. For example, physiotherapists are moving
into first point of contact roles for patients with musculoskeletal problems, where the ability to
prescribe enables them to provide a complete treatment package without referral to other
healthcare professionals [8–10]. These plans will be hindered if non-medical prescribers are
deterred from utilising their skills. Additionally, the approximate cost of training non-medical
prescribers was calculated as £10,000; failure to utilise this skill therefore represents poor use
of limited NHS funds [11].
Previous research evaluating the use of NMP indicated that approximately a third of quali-
fied Allied Health Professional prescribers may not prescribe compared to approximately 10%
of nurses [11, 12]. A systematic literature review described 15 factors or themes (for example,
medical support or facilities availability) potentially influencing prescribing utilisation by non-
medical professions [13]. The majority of included studies concerned nurse prescribing and
the remainder pharmacists. No papers reviewed the experiences of other non-medical pre-
scribers; hence it is unclear if other NMP professions experience similar factors affecting pre-
scribing utilisation. Establishing factors that facilitate or prevent NMP and investigating if
these are generic to the different NMP professions, or are professional, situational or person
specific will aid NMP development.
This paper presents the results of an investigation into facilitators and barriers encountered
by two NMP professions, pharmacy and physiotherapy. These professions were chosen as they
are similar sizes in the UK (approximately 50,000), may work individually or as teams, and
may work in all healthcare sectors [14, 15]. They differ in the length of time that each profes-
sion had prescribing rights, with pharmacy gaining independent prescribing rights six years
earlier than physiotherapy [16, 17].
The primary objective was to gain consensus regarding the factors that have supported, or
discouraged, pharmacist and physiotherapist non-medical prescribers from utilising their pre-
scribing qualification. Furthermore, to determine which factors had greatest influence on pre-




Research methods, such as consensus techniques, that systematically obtain and prioritise
expert opinion can be utilised when published information is scanty or non-existent [18, 19].
The Delphi technique was developed in the 1950s as a forecast method and has been
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increasingly used in healthcare research [20]. It is an iterative technique using sequential ques-
tionnaires and controlled group feedback, with anonymity of participants to each other as a
key feature [21, 22]. The classic Delphi design has an information seeking first-round followed
by prioritisation rounds, stopping when consensus is achieved. The literature describes varia-
tions, such as using literature reviews to generate the first round [20]. A previous systematic lit-
erature review [13], showing an absence of physiotherapist literature, indicated the
appropriateness of the classic Delphi information gathering first round to seek physiotherapy
opinions [22].
Questionnaires were administered using online survey software (https://www.
onlinesurveys.ac.uk/) supporting participant anonymity whilst providing response tracking
and automatic reminder facilities. The study was approved by the University of Birmingham’s
Science, Technology, Engineering and Mathematics Ethical Review Committee and all data
were held securely in accordance with university guidance. The study is reported in accor-
dance with the criteria proposed by Jünger and colleagues, in the absence of an agreed report-
ing structure for Delphi studies (S1 Appendix) [23].
Participants
Delphi participants are described as ‘experts’ and require knowledge of the research topic. A
criterion based purposive technique was adopted to recruit pharmacist and physiotherapist
independent prescribers, qualified since 2013 when the law was amended to permit physio-
therapist independent prescribing, using a sample matrix (S1 Table) [17, 24, 25]. Readily acces-
sible lists of such prescribers are unavailable, and recruitment was conducted indirectly.
Invitation emails were sent to West Midlands NMP Leads, CHAIN (a healthcare orientated
online mutual support network: www.chain-network.org.uk) and Health Education England
(a national body overseeing education: https://www.hee.nhs.uk) Pharmacy Deans, requesting
they forward the email invitation to physiotherapist and pharmacist prescribers. Invitations to
participate contained a brief study outline, participant information sheet and contact details.
Potential participants were invited to contact the lead researcher with questions and to express
their interest in participation. Sample sizes for Delphi exercises are variable, ranging from
fewer than 10 to several hundred, with smaller numbers suitable for homogenous samples
[21]. The current research sample was heterogenous since recruitment covered all healthcare
sectors and levels of experience. As the number of qualified physiotherapist independent pre-
scribers was unknown, a pragmatic target sample size of 30 for each profession was chosen.
Recruitment was closed in October 2018.
Procedure and analysis
A three round Delphi was conducted, following the scheme in Fig 1. People responding posi-
tively to the invitation email were sent an email link to the first questionnaire. Subsequent
questionnaires were sent to participants who responded to the previous questionnaire. Each
round was open for one month, with non-respondents sent reminder emails at two and three
weeks to maximise response rate [26–29]. Regular emails regarding the progress of the exercise
were sent to all participants to minimise response dropout; an acknowledged limitation of Del-
phi studies [27, 28]. The Round One questionnaire was piloted with nurse independent pre-
scribers and the questionnaires for Rounds Two and Three were reviewed by the research
group.
Round One. The Round One questionnaire comprised three sections (see S2 Appendix).
The first section included study information and a consent statement; participants could only
proceed further if consent was agreed. The second section requested brief demographic data.
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The third section, using open ended questions, asked participants to provide at least three facil-
itators and/or barriers to prescribing that they had encountered. Participants were able to
comment on questionnaire design and content.
Demographic data were imported into SPSS (IBM1 SPSS1 Statistics 25) for descriptive
statistics. The open responses, detailing barriers and facilitators, were exported into NVivo1
12 (QSR International) for content analysis [30–32]. The responses were reviewed and coded
to identify recurrent themes and used to develop the Round Two questionnaire [21, 26, 33].
Round Two. The Round Two questionnaire comprising the tabulated statements was sent
to all participants who had responded to Round One (see S3 Appendix). Participants were
asked to rate the importance of the factors in each statement to their practice through a
5-point Likert scale. [28, 34–36] and were able to add free text comments throughout to
explain their ratings.
Anonymous rating data were exported from the online survey software into an Excel
spreadsheet (Microsoft1 Excel for Mac 16) and thence into SPSS (IBM1 SPSS1 Statistics
25). Percentage agreement, median and interquartile range (IQR) were calculated for each
statement [21, 22, 28, 35]. The median and IQR were chosen as they are appropriate for ordi-
nal scales such as Likert [18, 21, 22, 28]. Kendall’s Coefficient of Concordance (W) was calcu-
lated as a measure of group response agreement [22, 37, 38]. Kendall’s Coefficient of
Concordance (W) results range from 0 (no agreement) to 1 (full agreement). Consensus crite-
ria, based on previous studies, were determined a priori (Table 1) [28, 35, 36, 39].
Round Three. The Round Three questionnaire was derived following analysis of Round
Two, using the decision criteria listed in Table 2. and was sent to all participants who had com-
pleted Round Two (see S4 Appendix). Participants received group median feedback on
Fig 1. Diagram describing the three Delphi rounds and the researcher and participant actions at each round.
https://doi.org/10.1371/journal.pone.0246273.g001
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statements included for re-rating and were invited to review and amend their rating, using the
same 0–5 Likert scale. Statements achieving consensus in Round Two were included sepa-
rately, with participants asked to rank the ten most important to them, from one to ten.
Consensus criteria analyses were calculated as described in Round Two. The number of
comments received in Round Two and Round Three were compared, with a decrease in num-
bers supporting stability in participant responses [40]. The ranking data were exported into an
Excel spreadsheet (Microsoft1 Excel for Mac 16) and weighted sum ranks calculated, allowing
ordering of statements (See S5 Appendix).
Results
Demographic data
Forty-nine participants expressed an interest in participating and received the Round One
questionnaire. The Round One questionnaire was completed by 42 participants (n = 24 phar-
macists, n = 18 physiotherapists). Participant demographic data is presented in Table 3. The
majority of physiotherapists (11/18) had been qualified in their profession for� 21 years, com-
pared to pharmacists (6/24). Secondary care was the predominant practice area for recruited
pharmacists (21/24), with physiotherapist practice areas distributed across all sectors. Physio-
therapists were also more likely to have a secondary practice area (7/18) than pharmacists (1/
24). More pharmacists were active prescribers (20/24) compared to physiotherapists (11/18).
Round One results
The number of statements received from each participant ranged between three and seven,
with 172 in total. Content analysis resulted in 24 major themes (see Table 4). Following
removal of duplicates, 127 statements were included in Round Two across the 24 themes (59
facilitators, 68 barriers). In many cases, participants elaborated on the statement using a free
text facility. For example, participant Pharm17 listed ‘effective personal development reviews’ as
a facilitator and expanded on it as follows:
‘effective PDR enable (sic) to identify areas of development and opportunities for expansion of
areas of practice’ Pharm17




Met all consensus criteria, for all participants and for individual professional groups
Included for re-
rating




Met one or no consensus criteria, for all participants and for individual professional groups
https://doi.org/10.1371/journal.pone.0246273.t002
Table 1. Consensus criteria for Rounds Two and Three.
Test Round Two Round Three
Percentage agreement 60 70
Median 3.5 4
Interquartile range �2 �1
Kendall’s Coefficient of Concordance (W) P<0.05 P<0.05
https://doi.org/10.1371/journal.pone.0246273.t001
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Table 3. Participant demographic data.
Demographics Pharmacists
(n = 24)
Physiotherapists (n = 18) Total (n = 42)
n % n % n %
Years qualified in profession �5 2 8.3 0 0 2 4.8
6–10 7 29.2 1 5.5 8 19.0
11–15 4 16.7 3 16.7 7 16.7
16–20 5 20.8 3 16.7 8 19.0
>21 6 25 11 61.1 17 40.5
Time qualified as independent prescriber �12 months 7 29.2 5 27.8 12 28.6
>12 months 17 70.8 13 72.2 30 71.4
Home nation in which they qualified England 23 95.8 18 100 41 97.6
Scotland 1 4.2 0 0 1 2.4
Wales 0 0 0 0 0 0
Northern Ireland 0 0 0 0 0 0
Main practice area Primary Care 3 12.5 5 27.8 8 19.0
Secondary care 21 87.5 6 33.3 27 64.3
Community 0 0 5 27.8 5 11.9
Other 0 0 Private practice 1 Mental health
services for older people 1
11.1 2 4.8
Secondary practice areas Primary Care 0 0 1 5.5 1 2.4
Secondary care 0 0 0 0 0 0
Community 1 4.2 4 22.2 5 11.9
Other 0 0 Private practice 1 Out-patients 1 11.1 2 4.8
Active prescriber Yes 20 83.3 11 61.1 31 73.8
No 4 16.7 7 38.9 11 26.2
Average number of prescriptions
written per week�
<5 5 20.8 7 38.9 12 28.6
6–15 7 29.2 3 16.7 10 23.8
16–25 2 8.3 1 5.5 3 7.1
26–35 3 12.5 0 0 3 7.1
36–45 1 4.2 0 0 1 2.4
>46 2 8.3 0 0 2 4.8
Type of practice§ Generalist 10 41.7 7 38.9 17 40.5
Specialist 13 54.2 11 61.1 24 57.1
Specialities listed Anticoagulation Critical care and respiratory
Antimicrobials MSK and pain
Clinical research/
cardiology
Pain Management (n = 2)



















PLOS ONE A Delphi study exploring barriers and facilitators to physiotherapist and pharmacist prescribing
PLOS ONE | https://doi.org/10.1371/journal.pone.0246273 February 2, 2021 6 / 17
Likewise, Physio05 gave ‘the Law’ as a barrier, elaborating with:
‘as a physio I am restricted to my prescribing. In most terms this is appropriate but it does
cause me to have to go to a GP for a prescription that I may have been able to do myself’
Physio05
Round Two results
Of participants completing Round One, n = 31 responded in Round Two. Kendall’s W was cal-
culated with the significance results indicating agreement between participants as a whole and
for pharmacists and physiotherapists separately (Table 5).
Twenty-nine statements reached consensus and included 28 facilitator and one barrier
statement. Of the 40 statements not reaching the consensus criteria, 10 were facilitators and 30
barriers and were removed from further rounds as described in Table 2. The remaining state-
ments were included for re-rating in Round Three. Full results are presented in supporting
information S2 and S3 Tables. Comments were received for most statements, with 300
received for facilitators (range 0–16 per statement), and 134 received for barriers (range 0–6
per statement). Comments included requests for more explanation (5% of all comments) or
indicated that the statement was irrelevant to themselves or their practice (facilitator state-
ments—30%, barrier statements—43%).
Table 4. Identified themes following content analysis of Round One results.
Theme Description Facilitator (n) Barrier (n)
Alternative
prescriber
As alternative to a doctor, or replaced by an alternative, possibly ’cheaper’ model 2 3
Clinical skills Clinical examination skills–acquisition or lack of. 1 2
Confidence Personal confidence in skills 2 2
Employer Support from Trust, department, manager etc 12 5
Funding Funding to practice 0 5
Information sources Access to information sources, use of information sources. Keeping up to date with new information. 3 2
Infrastructure Access to clinic room, prescription pads etc. 2 2
Knowledge Experience in prescribing area (or lack of). Specialist knowledge. 6 1
Legal Aspects Prescribing legislation, indemnity, registration 4 9
Medical Records Access to medical records—paper or electronic 3 5
Medical support Medical support—GP/Consultant etc. Includes acceptance of role etc.. 19 6
Nursing support Relationship with nursing staff. Could be supportive or indicate lack of understanding of the role. 2 2
Patients Patient experience and knowledge of NMP. 5 0
Peer support Other colleagues and clinicians. 12 5
Post Course Support Post course development including appraisals 3 2
Prescribing budget Access to prescribing budget 1 1
Prescribing Course Usefulness/appropriateness of course. Aspects relating to communication from the university during and
following course completion.
0 3
Prescription review Pharmacy review of prescriptions. Includes need for second pharmacist. 1 5
Role Personal job role. Includes effect of change in role. 2 7
Role model Acting as a role model. Being inspired by other role models. 2 0
Time Time to prescribe, time free from other duties etc. 0 10
Ward round Role and attendance on ward rounds. Attendance at MDT meeting. 1 2
Working
environment
Totality of working environment, including protocols and policies guiding activity. 2 3
Minor themes Competency, formulary, practice area, external drivers and working patterns 1 4
https://doi.org/10.1371/journal.pone.0246273.t004
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Round Three results
Of the 31 participants receiving the Round Three questionnaire, 20 responded. No further
statements reached consensus following re-rating (see S4 and S5 Tables). Round Three Ken-
dall’s W is reported in Table 6, indicating agreement except for the facilitator statements from
physiotherapists. Fewer comments were received, compared with Round Two, indicating sta-
bility within responses (30 for facilitators [range 0–4 per statement], 11 for barriers [range 0–1
per statement]). However, a small number of comments indicated a failure to understand the
limitations imposed on selected professions. For example, a pharmacist responded to the state-
ment: “Lack of medical cover at times means I cannot prescribe opioids” with:
“Why would this be an issue?” Pharm12
Table 7 reports Kendall’s W for the ranking exercise and indicates agreement within groups
(p>0.05). Table 8 lists the weighted rank sums, for all participants and each profession. The
ranks for all participants are presented graphically in Fig 2 and for each profession in Fig 3.
The highest ranked statement was common to all participants and to each profession:
“Being able to prescribe to patients is more effective and really useful working [in my area]”
Differences are noted when the top ten ranked statements from all participants are com-
pared with either the pharmacist or physiotherapist groups. Statements made by the
Table 5. Kendall’s Coefficient of Concordance (W) results for Round Two.
Group Population n Kendall’s W Chi-Square df Significance
All statements Total group 31 .284 1110.893 126 <0.01
Pharmacists 14 .393 692.609 126 <0.01
Physiotherapists 17 .294 629.334 126 <0.01
Facilitator statements Total group, 31 .234 420.712 58 <0.01
Pharmacists, 14 .333 270.610 58 <0.01
Physiotherapists 17 .230 226.642 58 <0.01
Barrier statements Total group 31 .090 187.220 67 <0.01
Pharmacists 14 .223 209.178 67 <0.01
Physiotherapists 17 .151 171.609 67 <0.01
https://doi.org/10.1371/journal.pone.0246273.t005
Table 6. Kendall’s Coefficient of Concordance (W) results for Round Three re-rating of statements.
Group Population n Kendall’s W Chi-Square df Significance
All statements Total group 20 .207 236.360 57 <0.01
Pharmacists 10 .302 172.251 57 <0.01
Physiotherapists 10 .306 174.689 57 <0.01
Facilitator statements Total group, 20 .071 28.235 20 .104
Pharmacists, 10 .191 38.165 20 .008
Physiotherapists 10 .122 24.444 20 .224
Barrier statements Total group 20 .128 92.162 36 <0.01
Pharmacists 10 .287 103.400 36 <0.01
Physiotherapists 10 .231 83.039 36 <0.01
https://doi.org/10.1371/journal.pone.0246273.t006
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pharmacist group concur with the top ten statements from all participants, albeit in a different
rank order. When the top ten statements for physiotherapists and all participants are com-
pared, three statements differ. In the pharmacist top ten, all weighted sums for statements
were�30, however only the top five for physiotherapists were�30. The weighted sums for
remaining statements for physiotherapists were low, with tied ranks affecting 17 statements.
Discussion
This is the first study to identify the factors influencing the uptake and utilisation of prescrib-
ing by physiotherapists and pharmacists and to investigate if each profession perceived them
similarly. A similar number of barriers and facilitators were identified in Round One. Follow-
ing Round Two, consensus was obtained for 28/59 facilitator statements, but only 1/68 barrier
statements, with no further consensus achieved after Round Three. It is striking that despite
the greater initial number of barrier statements, only one achieved consensus. This suggests
that most NMP barriers are specific to the post and person, whereas facilitators are generic.
Of the themes identified from content analysis, 13 had statements achieving consensus.
“Medical professionals” was the most highly cited theme, reinforcing the importance of their
support for NMP identified in a previous literature review [13]. A disproportionately high
number of medical professional statements reached consensus (7/29) in Round Two compared
with other themes. Similar numbers of statements relating to patient care (4/29) and employer
(4/29) themes achieved consensus. Themes such as medical records and infrastructure
highlighted in a previous literature review [13] did not have statements reaching consensus.
The ranking results emphasised the importance of prescribing to patient care, with the fore-
most statement overall concerning the effectiveness of prescribing for patients. Both profes-
sions highlighted the benefit of streamlining care for patients. Additionally, pharmacists
ranked highly the statement regarding motivation to help patients benefit from reduced delay
and duplication, possibly driven by perceived secondary care hinderances in prescribing medi-
cation. Pharmacists and physiotherapists ranked practice related statements in their top ten
statement ranking, highlighting the importance to their role. In particular these related to the
benefit of a specialist area in allowing the development of skills and knowledge and building
confidence. Both professions ranked good working relationships with consultants in their top
ten. Subtle differences in the manner in which pharmacists and physiotherapists practice were
highlighted by the distribution of statements in the top ten. Pharmacists ranked the three state-
ments mentioning teams in their top ten (direct contact with medical team, working as part of
a multidisciplinary team and support from team) showing the importance of team working in
their practice. In comparison the physiotherapist top ten highlighted the benefits of multidisci-
plinary teams but also supportive nursing and medical colleagues, suggesting a more indepen-
dent mode of working. Only physiotherapists ranked an employer support statement in their
top ten statement ranking, which may be driven by the newness of prescribing to physiothera-
pists and the need for employer support. In comparison, several pharmacists commented that
they had changed employer since qualifying as an independent prescriber. Outside the top ten,
the weighted rank sums for the remaining statements for both groups were small; rendering
Table 7. Kendall’s Coefficient of Concordance (W) for ranked statements.
Population n Kendall’s W Chi-Square df Significance
Total group 20 .132 73.812 28 <0.01
Pharmacists 10 .185 51.761 28 .004
Physiotherapists 10 .168 47.014 28 .014
https://doi.org/10.1371/journal.pone.0246273.t007
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Being able to prescribe to patients is more effective
and really useful working [in my area]
917 1 201 1 280 1
Having a speciality allows development of skills
and knowledge
164 2 38 8 94 2
Direct contact with medical team caring for
patient
160 3 95 2 17 14
Motivation to help the patients who will benefit
with prescribing and cut care delay / duplication
157 4 90 3 13 16
Patient requirements. A need for patients to have
streamlined care by being able to prescribe at the
point of contact
139 5 36 9 39 4
Good relationship with consultants 128 6 46 5 30 5
Working as part of an MDT [multidisciplinary
team] / interdisciplinary group
90 7 40 7 24 6
Personal confidence in specialism 88 8 45 6 21 9
Well supported by team and they allow me to
prescribe for their patients
69 9 60 4 9 20
My knowledge of medication 62 10 34 10 24 6
Supportive nursing colleagues 54 11 5 24 43 3
Easy access to medication info 49 12 19 12 18 12
Clinical supervision with a [doctor] has massively
helped me increase my confidence prescribing
44 13 14 17 16 15
My employer has provided the support for me to
be able to go on the NMP course and then
supported me once qualified
44 13 16 14 24 6
Forward thinking DMP [designated medical
practitioner] who is keen to integrate different
MDG [multidisciplinary group] professionals into
the team
38 15 14 17 18 12
Lack of time to develop further prescribing skills 35 16 15 15 20 11
Supportive medical colleagues 32 17 3 25 21 9
Great antibiotic guidelines in this trust/area 27 18 20 11 7 23
Support from the employer/department for the
role of non-medical prescribers
26 19 15 15 11 18
Doctors have been working [with] this [NMP]
model
19 20 9 21 10 19
Management support enables funding and training
time to qualify as a prescriber
19 20 10 20 9 20
Supportive working environment [with NMP]
policies in place
18 22 12 19 6 24
Support from my line manager 17 23 17 13 0 28
The nature of the role facilitates prescribing
practice as part of the overall review of patients
16 24 7 22 9 20
Supportive medical supervision / mentorship 13 25 0 28 13 16
Wide variety of options that you can offer patients
to improve their experience
13 25 7 22 6 24
The law enables me to practice as an NMP 9 27 1 27 6 24
Support from other NMPs 4 28 0 28 4 27
Mentor already NMP—creates a positive
environment for NMP
3 29 3 25 0 28
https://doi.org/10.1371/journal.pone.0246273.t008
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them inappropriate as discriminators. The only barrier reaching consensus concerned the lack
of time to develop skills and was ranked 16th overall and outside the top ten for both pharma-
cists and physiotherapists, implying that while this was a concern, it was not a major deterrent
to prescribing.
Equal numbers of pharmacists and physiotherapists completed Round Three, with poten-
tially the same weighted rank sum, so it is surprising that the physiotherapist weighted rank
sums were relatively low compared with pharmacy results. This may be explained by the vari-
ety of physiotherapy practice areas and associated factors indicated by the participants. This
compares to pharmacists who were primarily recruited from secondary care.
Initially more pharmacist than physiotherapist prescribers were recruited, reflecting both
difficulty in accessing physiotherapist prescribers and differences in prescribing legislation
dates [17, 41]. Physiotherapists were more likely to have been registered in their profession
longer than pharmacists. This reflects previous early prescribing studies which suggested that
more experienced professionals adopted prescribing initially after its introduction to their pro-
fession [42–46]. Recruited physiotherapists worked in several healthcare settings, whereas
pharmacists were mainly from secondary care. Pharmacists were more inclined to be active
prescribers, which may reflect how embedded pharmacist prescribing has become, although
several comments indicated that pharmacists were now in roles that did not support
prescribing.
The relevance of the topic was indicated by the Round One response rate (85%), and the
number of barriers and facilitators initially identified. Comments received for each round sup-
ported the high engagement level of the participants. Despite steps taken to minimise drop-
out, the response rate decreased over the three rounds, with a final response rate representing
Fig 2. Ranked statements for all participants by weighted rank sum.
https://doi.org/10.1371/journal.pone.0246273.g002
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41% of the initial 49 participants. The survey software enabled the overall progress through
each questionnaire to be reviewed, indicating the potential for questionnaire design and survey
software constraints to contribute to the attrition. For Round Two, a balance was required
between returning all the statements back to participants, risking disengagement if apparent
repetition, and grouping similar statements as a single statement, risking introducing
researcher bias [26, 38]. Consequently, the decision was made to only omit those where there
was evident duplication. Supported by participant comments in Round Two, statements were
removed from Round Three (as described earlier) rendering the questionnaire more manage-
able, whilst accepting the potential introduction of bias [26, 38]. The survey software con-
straints resulted in sub-optimal display for the ranking question, with participants
commenting that selecting their top ten was challenging.
A small number of comments were received from pharmacist participants indicating they
were unaware of prescribing constraints for some professions, or they had forgotten there
were physiotherapy participants. Failure to understand these constraints is concerning as it
indicates that pharmacists, responsible for dispensing prescriptions, are unfamiliar with pre-
scribing regulations [4].
The two professions were initially selected because of the difference in independent pre-
scribing implementation stage, with pharmacists having a six-year potential advantage over
Fig 3. Ranked statements for professional groups by weighted rank sum.
https://doi.org/10.1371/journal.pone.0246273.g003
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physiotherapists. This time difference is most apparent when the participant demographics are
reviewed, with physiotherapists tending to be both more experienced practitioners and less
likely to be actively prescribing compared to pharmacists. However, when the ranked state-
ments are reviewed the differences between the groups would appear to be more related to
practice areas and mode of practice, than to prescribing implementation stage. The exception
is the support from employers that the physiotherapist group ranked in their top ten, whereas
for pharmacists this was not perceived to be as important an issue.
Strengths and limitations
This is the first study investigating and comparing prescribing barriers and facilitators in phar-
macy and physiotherapy professions. The participants’ level of engagement, emphasised by the
Round One responses and free text comments, highlight the relevance of the topic.
The recruitment strategy relied on self-identifying participants, potentially introducing bias
as participants with strong views are more inclined to volunteer [26]. Accessing physiothera-
pist prescribers also proved difficult, with an initial imbalance in participant numbers. Partici-
pant fatigue and attrition are recognised Delphi limitations [27, 28] and this was evident,
despite approaches to minimise attrition. Software limitations influenced questionnaire
design, deterring participants from completing Round Two and Three, and affecting response
rate.
Conclusion
This study set out to explore the factors (both facilitators and barriers) that affected pharmacist
and physiotherapist prescribing, and to determine if there were differences between the two
professional groups. Initially similar numbers of facilitator and barrier statements were identi-
fied by participants, but only one barrier statement reached consensus, compared to 28 facilita-
tor statements. Improving patient care and medical professionals’ support appear to be the
most important factors in enabling non-medical prescribing. In contrast the lack of time to
develop prescribing skills was the only barrier to reach consensus. These results indicate that
prescribing barriers are post and person specific, whereas facilitators are more likely to be
generic. Differences in the ranking of facilitator statements were detected between pharmacy
and physiotherapy, appearing to reflect the manner in which the two professions practice. In
particular pharmacists favoured factors relating to team support whereas these were less
important for physiotherapists who may work more independently. This intimates that factors
identified in a previous literature review [13] may not be universally applicable to all NMP pro-
fessions. Participants’ opinions shape Delphi results and further research is required to deter-
mine the transferability of these results [20, 47].
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